jhanvi kukreja
The global cancer immunotherapy market is on a promising trajectory, with a projected value increase from USD 134.40 billion in 2024 to USD 346.63 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.8%. This innovative therapeutic approach leverages the body’s immune system to identify and combat cancer cells, presenting a compelling alternative to traditional treatments like chemotherapy and radiation, which often come with significant side effects.
{{msg}}
{{record.title}} at {{record.organization_name}}
{{record.monthNameStart}} {{record.yearStart}}
{{record.description}}
I'M LOOKING FOR
Not speficied